Bosnia and Herzegovina - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Bosnia and Herzegovina Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes increased 4.4% year on year. At €103.12 Per Capita in 2019, the country was ranked number 33 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes. Switzerland lead the ranking with €1,048.7 Per Capita in 2019, an increase of 2.6% versus 2018. Liechtenstein, Germany and Belgium respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +7.4% per year, while Greece witnessed the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 103.12 |
| 2018 | 102.37 |
| 2017 | 99.67 |
| 2016 | 97.11 |
| 2015 | 89.71 |
Download all data from 2013 to 2019
How does Bosnia and Herzegovina rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data | |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data | |
| 32 |
#32
Romania
|
141.70 | 2019 | -1.7 % | +1.1 % | View data | |
| 33 |
#33
Bosnia and Herzegovina
|
103.12 | 2019 | +0.7 % | +4.3 % | View data | |